Dopamine autoreceptor stimulation: Clinical significance

Herbert Y. Meltzer*

*Corresponding author for this work

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Recent studies of the effects of low doses of dopamine agonists, designed to stimulate dopamine autoreceptors and hence diminish the synthesis and release of dopamine, were based on a series of basic research studies which demonstrated the existence of autoreceptors on dopamine neurones of the nigrostriatal, mesolimbic and mesocortical dopaminergic neurones. Evidence for autoreceptors on the tuberoinfundibular dopamine neurones which participate in the regulation of prolactin and growth hormone secretion is lacking. Some recent reports have questioned the existence of dopamine autoreceptors on the mesolimbic and nigrostriatal dopamine neurones. Specificity of various dopamine agonists and antagonists for the dopamine autoreceptor will be reviewed. The sedative, anxiolytic, antipsychotic, antidyskinetic and neuroendocrine effects of low dose dopamine agonists in man will be described. Low dose apomorphine, N-propylapomorphine and bromocriptine have been reported to have antipsychotic effects in the major psychoses, to diminish tardive dyskinesia and to enhance extrapiramidal insufficiency. A unique depressive state which developed in a small proportion of psychiatric patients after low dose apomorphine will be described. Further evidence for the lack of dopamine autoreceptors on the tuberoinfundibular dopamine neurones in man will be presented. Strategies for further study of the dopamine autoreceptor concept in man will be discussed.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalPharmacology, Biochemistry and Behavior
Volume17
Issue numberSUPPL. 1
DOIs
StatePublished - 1982

Fingerprint

Autoreceptors
Dopamine
Dopaminergic Neurons
Dopamine Agonists
Neurons
Apomorphine
Antipsychotic Agents
Bromocriptine
Dopamine Antagonists
Anti-Anxiety Agents
Hypnotics and Sedatives
Prolactin
Psychotic Disorders
Growth Hormone
Psychiatry
Research

Keywords

  • Autoreceptors
  • Dopamine agonists
  • Dopamine neurons

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience

Cite this

@article{1c27d2b349454a868f18b740285d95a2,
title = "Dopamine autoreceptor stimulation: Clinical significance",
abstract = "Recent studies of the effects of low doses of dopamine agonists, designed to stimulate dopamine autoreceptors and hence diminish the synthesis and release of dopamine, were based on a series of basic research studies which demonstrated the existence of autoreceptors on dopamine neurones of the nigrostriatal, mesolimbic and mesocortical dopaminergic neurones. Evidence for autoreceptors on the tuberoinfundibular dopamine neurones which participate in the regulation of prolactin and growth hormone secretion is lacking. Some recent reports have questioned the existence of dopamine autoreceptors on the mesolimbic and nigrostriatal dopamine neurones. Specificity of various dopamine agonists and antagonists for the dopamine autoreceptor will be reviewed. The sedative, anxiolytic, antipsychotic, antidyskinetic and neuroendocrine effects of low dose dopamine agonists in man will be described. Low dose apomorphine, N-propylapomorphine and bromocriptine have been reported to have antipsychotic effects in the major psychoses, to diminish tardive dyskinesia and to enhance extrapiramidal insufficiency. A unique depressive state which developed in a small proportion of psychiatric patients after low dose apomorphine will be described. Further evidence for the lack of dopamine autoreceptors on the tuberoinfundibular dopamine neurones in man will be presented. Strategies for further study of the dopamine autoreceptor concept in man will be discussed.",
keywords = "Autoreceptors, Dopamine agonists, Dopamine neurons",
author = "Meltzer, {Herbert Y.}",
year = "1982",
doi = "10.1016/0091-3057(82)90504-4",
language = "English (US)",
volume = "17",
pages = "1--10",
journal = "Pharmacology, Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "SUPPL. 1",

}

Dopamine autoreceptor stimulation : Clinical significance. / Meltzer, Herbert Y.

In: Pharmacology, Biochemistry and Behavior, Vol. 17, No. SUPPL. 1, 1982, p. 1-10.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dopamine autoreceptor stimulation

T2 - Clinical significance

AU - Meltzer, Herbert Y.

PY - 1982

Y1 - 1982

N2 - Recent studies of the effects of low doses of dopamine agonists, designed to stimulate dopamine autoreceptors and hence diminish the synthesis and release of dopamine, were based on a series of basic research studies which demonstrated the existence of autoreceptors on dopamine neurones of the nigrostriatal, mesolimbic and mesocortical dopaminergic neurones. Evidence for autoreceptors on the tuberoinfundibular dopamine neurones which participate in the regulation of prolactin and growth hormone secretion is lacking. Some recent reports have questioned the existence of dopamine autoreceptors on the mesolimbic and nigrostriatal dopamine neurones. Specificity of various dopamine agonists and antagonists for the dopamine autoreceptor will be reviewed. The sedative, anxiolytic, antipsychotic, antidyskinetic and neuroendocrine effects of low dose dopamine agonists in man will be described. Low dose apomorphine, N-propylapomorphine and bromocriptine have been reported to have antipsychotic effects in the major psychoses, to diminish tardive dyskinesia and to enhance extrapiramidal insufficiency. A unique depressive state which developed in a small proportion of psychiatric patients after low dose apomorphine will be described. Further evidence for the lack of dopamine autoreceptors on the tuberoinfundibular dopamine neurones in man will be presented. Strategies for further study of the dopamine autoreceptor concept in man will be discussed.

AB - Recent studies of the effects of low doses of dopamine agonists, designed to stimulate dopamine autoreceptors and hence diminish the synthesis and release of dopamine, were based on a series of basic research studies which demonstrated the existence of autoreceptors on dopamine neurones of the nigrostriatal, mesolimbic and mesocortical dopaminergic neurones. Evidence for autoreceptors on the tuberoinfundibular dopamine neurones which participate in the regulation of prolactin and growth hormone secretion is lacking. Some recent reports have questioned the existence of dopamine autoreceptors on the mesolimbic and nigrostriatal dopamine neurones. Specificity of various dopamine agonists and antagonists for the dopamine autoreceptor will be reviewed. The sedative, anxiolytic, antipsychotic, antidyskinetic and neuroendocrine effects of low dose dopamine agonists in man will be described. Low dose apomorphine, N-propylapomorphine and bromocriptine have been reported to have antipsychotic effects in the major psychoses, to diminish tardive dyskinesia and to enhance extrapiramidal insufficiency. A unique depressive state which developed in a small proportion of psychiatric patients after low dose apomorphine will be described. Further evidence for the lack of dopamine autoreceptors on the tuberoinfundibular dopamine neurones in man will be presented. Strategies for further study of the dopamine autoreceptor concept in man will be discussed.

KW - Autoreceptors

KW - Dopamine agonists

KW - Dopamine neurons

UR - http://www.scopus.com/inward/record.url?scp=0020365520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020365520&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(82)90504-4

DO - 10.1016/0091-3057(82)90504-4

M3 - Article

C2 - 6223322

AN - SCOPUS:0020365520

VL - 17

SP - 1

EP - 10

JO - Pharmacology, Biochemistry and Behavior

JF - Pharmacology, Biochemistry and Behavior

SN - 0091-3057

IS - SUPPL. 1

ER -